Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer
Gespeichert in:
Veröffentlicht in: | Annals of oncology 2019-06, Vol.30 (6), p.1017-1017 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1017 |
---|---|
container_issue | 6 |
container_start_page | 1017 |
container_title | Annals of oncology |
container_volume | 30 |
creator | Baselga, J Manikhas, A Cortés, J Llombart, A Roman, L Semiglazov, V F Byakhov, M Lokanatha, D Forenza, S Goldfarb, R H Matera, J Azarnia, N Hudis, C A Rozencweig, M |
description | |
doi_str_mv | 10.1093/annonc/mdy529 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2165660175</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2165660175</sourcerecordid><originalsourceid>FETCH-LOGICAL-p141t-f84d228c6e7b4c387ad9aacb05a0f0903546381099fbc4118c8cc86e123559863</originalsourceid><addsrcrecordid>eNo1kEFLwzAUx4Mgbk6PXiVHL9WkabPkKGO6wUARPZeXNHWRNqlNqpsfws9sxAkP3oP3-_8Of4QuKLmmRLIbcM47fdPV-zKXR2hKSy4zQQo6QachvBFCuMzlCZowwvOCUz5F349bCAav12scBwst9g1Okt687luIpsat7X3wXfrUfueHUVltHU6jfaesg2i9w582blMeQhy_xg4UBlfjHnRrI-xM-4uvlk95llQ22g-DOxMTnMIaq8GkE2tw2gxn6LiBNpjzw56hl7vl82KVbR7u14vbTdbTgsasEUWd50JzM1eFZmIOtQTQipRAGiIJKwvOROpENkoXlAottBbc0JyVpRSczdDVn7cf_PtoQqw6G7RpW3DGj6HKKS85J3ReJvTygI6qM3XVD7aDYV_9d8h-AL-CdRs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2165660175</pqid></control><display><type>article</type><title>Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Baselga, J ; Manikhas, A ; Cortés, J ; Llombart, A ; Roman, L ; Semiglazov, V F ; Byakhov, M ; Lokanatha, D ; Forenza, S ; Goldfarb, R H ; Matera, J ; Azarnia, N ; Hudis, C A ; Rozencweig, M</creator><creatorcontrib>Baselga, J ; Manikhas, A ; Cortés, J ; Llombart, A ; Roman, L ; Semiglazov, V F ; Byakhov, M ; Lokanatha, D ; Forenza, S ; Goldfarb, R H ; Matera, J ; Azarnia, N ; Hudis, C A ; Rozencweig, M</creatorcontrib><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdy529</identifier><identifier>PMID: 30624616</identifier><language>eng</language><publisher>England</publisher><ispartof>Annals of oncology, 2019-06, Vol.30 (6), p.1017-1017</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30624616$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Baselga, J</creatorcontrib><creatorcontrib>Manikhas, A</creatorcontrib><creatorcontrib>Cortés, J</creatorcontrib><creatorcontrib>Llombart, A</creatorcontrib><creatorcontrib>Roman, L</creatorcontrib><creatorcontrib>Semiglazov, V F</creatorcontrib><creatorcontrib>Byakhov, M</creatorcontrib><creatorcontrib>Lokanatha, D</creatorcontrib><creatorcontrib>Forenza, S</creatorcontrib><creatorcontrib>Goldfarb, R H</creatorcontrib><creatorcontrib>Matera, J</creatorcontrib><creatorcontrib>Azarnia, N</creatorcontrib><creatorcontrib>Hudis, C A</creatorcontrib><creatorcontrib>Rozencweig, M</creatorcontrib><title>Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNo1kEFLwzAUx4Mgbk6PXiVHL9WkabPkKGO6wUARPZeXNHWRNqlNqpsfws9sxAkP3oP3-_8Of4QuKLmmRLIbcM47fdPV-zKXR2hKSy4zQQo6QachvBFCuMzlCZowwvOCUz5F349bCAav12scBwst9g1Okt687luIpsat7X3wXfrUfueHUVltHU6jfaesg2i9w582blMeQhy_xg4UBlfjHnRrI-xM-4uvlk95llQ22g-DOxMTnMIaq8GkE2tw2gxn6LiBNpjzw56hl7vl82KVbR7u14vbTdbTgsasEUWd50JzM1eFZmIOtQTQipRAGiIJKwvOROpENkoXlAottBbc0JyVpRSczdDVn7cf_PtoQqw6G7RpW3DGj6HKKS85J3ReJvTygI6qM3XVD7aDYV_9d8h-AL-CdRs</recordid><startdate>20190601</startdate><enddate>20190601</enddate><creator>Baselga, J</creator><creator>Manikhas, A</creator><creator>Cortés, J</creator><creator>Llombart, A</creator><creator>Roman, L</creator><creator>Semiglazov, V F</creator><creator>Byakhov, M</creator><creator>Lokanatha, D</creator><creator>Forenza, S</creator><creator>Goldfarb, R H</creator><creator>Matera, J</creator><creator>Azarnia, N</creator><creator>Hudis, C A</creator><creator>Rozencweig, M</creator><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20190601</creationdate><title>Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer</title><author>Baselga, J ; Manikhas, A ; Cortés, J ; Llombart, A ; Roman, L ; Semiglazov, V F ; Byakhov, M ; Lokanatha, D ; Forenza, S ; Goldfarb, R H ; Matera, J ; Azarnia, N ; Hudis, C A ; Rozencweig, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p141t-f84d228c6e7b4c387ad9aacb05a0f0903546381099fbc4118c8cc86e123559863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Baselga, J</creatorcontrib><creatorcontrib>Manikhas, A</creatorcontrib><creatorcontrib>Cortés, J</creatorcontrib><creatorcontrib>Llombart, A</creatorcontrib><creatorcontrib>Roman, L</creatorcontrib><creatorcontrib>Semiglazov, V F</creatorcontrib><creatorcontrib>Byakhov, M</creatorcontrib><creatorcontrib>Lokanatha, D</creatorcontrib><creatorcontrib>Forenza, S</creatorcontrib><creatorcontrib>Goldfarb, R H</creatorcontrib><creatorcontrib>Matera, J</creatorcontrib><creatorcontrib>Azarnia, N</creatorcontrib><creatorcontrib>Hudis, C A</creatorcontrib><creatorcontrib>Rozencweig, M</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Baselga, J</au><au>Manikhas, A</au><au>Cortés, J</au><au>Llombart, A</au><au>Roman, L</au><au>Semiglazov, V F</au><au>Byakhov, M</au><au>Lokanatha, D</au><au>Forenza, S</au><au>Goldfarb, R H</au><au>Matera, J</au><au>Azarnia, N</au><au>Hudis, C A</au><au>Rozencweig, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2019-06-01</date><risdate>2019</risdate><volume>30</volume><issue>6</issue><spage>1017</spage><epage>1017</epage><pages>1017-1017</pages><eissn>1569-8041</eissn><cop>England</cop><pmid>30624616</pmid><doi>10.1093/annonc/mdy529</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | EISSN: 1569-8041 |
ispartof | Annals of oncology, 2019-06, Vol.30 (6), p.1017-1017 |
issn | 1569-8041 |
language | eng |
recordid | cdi_proquest_miscellaneous_2165660175 |
source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
title | Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T09%3A04%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phase%20III%20trial%20of%20nonpegylated%20liposomal%20doxorubicin%20in%20combination%20with%20trastuzumab%20and%20paclitaxel%20in%20HER2-positive%20metastatic%20breast%20cancer&rft.jtitle=Annals%20of%20oncology&rft.au=Baselga,%20J&rft.date=2019-06-01&rft.volume=30&rft.issue=6&rft.spage=1017&rft.epage=1017&rft.pages=1017-1017&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdy529&rft_dat=%3Cproquest_pubme%3E2165660175%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2165660175&rft_id=info:pmid/30624616&rfr_iscdi=true |